133 related articles for article (PubMed ID: 37651310)
1. Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications.
Weigelt B; Marra A; Selenica P; Rios-Doria E; Momeni-Boroujeni A; Berger MF; Arora K; Nemirovsky D; Iasonos A; Chakravarty D; Abu-Rustum NR; Da Cruz Paula A; Dessources K; Ellenson LH; Liu YL; Aghajanian C; Brown CL
Cancer Discov; 2023 Nov; 13(11):2356-2369. PubMed ID: 37651310
[TBL] [Abstract][Full Text] [Related]
2. Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer.
Da Cruz Paula A; DeLair DF; Ferrando L; Fix DJ; Soslow RA; Park KJ; Chiang S; Reis-Filho JS; Zehir A; Donoghue MTA; Wu M; Brown DN; Murali R; Friedman CF; Zamarin D; Makker V; Mueller JJ; Leitao MM; Abu-Rustum NR; Aghajanian C; Weigelt B
Gynecol Oncol; 2021 May; 161(2):535-544. PubMed ID: 33622519
[TBL] [Abstract][Full Text] [Related]
3. Differences in the microbial profiles of early stage endometrial cancers between Black and White women.
Hawkins GM; Burkett WC; McCoy AN; Nichols HB; Olshan AF; Broaddus R; Merker JD; Weissman B; Brewster WR; Roach J; Keku TO; Bae-Jump V
Gynecol Oncol; 2022 May; 165(2):248-256. PubMed ID: 35277280
[TBL] [Abstract][Full Text] [Related]
4. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
[TBL] [Abstract][Full Text] [Related]
5. Racial disparities in molecular subtypes of endometrial cancer.
Dubil EA; Tian C; Wang G; Tarney CM; Bateman NW; Levine DA; Conrads TP; Hamilton CA; Maxwell GL; Darcy KM
Gynecol Oncol; 2018 Apr; 149(1):106-116. PubMed ID: 29605044
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiles of endometrial cancer tumors among Black patients.
Wilhite AM; Baca Y; Xiu J; Paladugu R; ElNaggar AC; Brown J; Winer IS; Morris R; Erickson BK; Olawaiye AB; Powell M; Korn WM; Rocconi RP; Khabele D; Jones NL
Gynecol Oncol; 2022 Jul; 166(1):108-116. PubMed ID: 35490034
[TBL] [Abstract][Full Text] [Related]
7. Impact of age at diagnosis on racial disparities in endometrial cancer patients.
Tarney CM; Tian C; Wang G; Dubil EA; Bateman NW; Chan JK; Elshaikh MA; Cote ML; Schildkraut JM; Shriver CD; Conrads TP; Hamilton CA; Maxwell GL; Darcy KM
Gynecol Oncol; 2018 Apr; 149(1):12-21. PubMed ID: 28800945
[TBL] [Abstract][Full Text] [Related]
8. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.
Liu YL; Gordhandas S; Arora K; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Zhou Q; Iasonos A; Carrot-Zhang J; Manning-Geist B; Sia TY; Selenica P; Vanderbilt C; Misyura M; Latham A; Bandlamudi C; Berger MF; Hamilton JG; Makker V; Abu-Rustum NR; Ellenson LH; Offit K; Mandelker DL; Stadler Z; Weigelt B; Aghajanian C; Brown C
Cancer; 2024 Feb; 130(4):576-587. PubMed ID: 37886874
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of somatic POLE mutations in endometrial carcinoma.
León-Castillo A; Britton H; McConechy MK; McAlpine JN; Nout R; Kommoss S; Brucker SY; Carlson JW; Epstein E; Rau TT; Bosse T; Church DN; Gilks CB
J Pathol; 2020 Mar; 250(3):323-335. PubMed ID: 31829442
[TBL] [Abstract][Full Text] [Related]
11. Analysis of endometrial carcinoma TCGA reveals differences in DNA methylation in tumors from Black and White women.
Asif H; Foley G; Simon M; Roque D; Kim JJ
Gynecol Oncol; 2023 Mar; 170():1-10. PubMed ID: 36580834
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.
Whelan K; Dillon M; Strickland KC; Pothuri B; Bae-Jump V; Borden LE; Thaker PH; Haight P; Arend RC; Ko E; Jackson AL; Corr BR; Ayoola-Adeola M; Wright JD; Podwika S; Smitherman C; Thomas S; Lightfoot M; Newton M; Washington C; Mullen M; Cosgrove C; Harsono AAH; Powell K; Herzog TJ; Salani R; Alvarez Secord A
Gynecol Oncol; 2023 Nov; 178():44-53. PubMed ID: 37748270
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.
Ross DS; Devereaux KA; Jin C; Lin DY; Zhang Y; Marra A; Makker V; Weigelt B; Ellenson LH; Chui MH
Mod Pathol; 2022 Jul; 35(7):962-971. PubMed ID: 34972830
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and Genomic Analysis of
Momeni-Boroujeni A; Dahoud W; Vanderbilt CM; Chiang S; Murali R; Rios-Doria EV; Alektiar KM; Aghajanian C; Abu-Rustum NR; Ladanyi M; Ellenson LH; Weigelt B; Soslow RA
Clin Cancer Res; 2021 May; 27(9):2613-2623. PubMed ID: 33602681
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer risk and trends among distinct African descent populations.
Medina HN; Penedo FJ; Joachim C; Deloumeaux J; Koru-Sengul T; Macni J; Bhakkan B; Peruvien J; Schlumbrecht MP; Pinheiro PS
Cancer; 2023 Sep; 129(17):2717-2726. PubMed ID: 37357566
[TBL] [Abstract][Full Text] [Related]
16. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.
Maxwell GL; Risinger JI; Hayes KA; Alvarez AA; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 2000 Aug; 6(8):2999-3005. PubMed ID: 10955777
[TBL] [Abstract][Full Text] [Related]
17. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.
Campbell JD; Lathan C; Sholl L; Ducar M; Vega M; Sunkavalli A; Lin L; Hanna M; Schubert L; Thorner A; Faris N; Williams DR; Osarogiagbon RU; van Hummelen P; Meyerson M; MacConaill L
JAMA Oncol; 2017 Jun; 3(6):801-809. PubMed ID: 28114446
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer: stage at diagnosis and associated factors in black and white patients.
Barrett RJ; Harlan LC; Wesley MN; Hill HA; Chen VW; Clayton LA; Kotz HL; Eley JW; Robboy SJ; Edwards BK
Am J Obstet Gynecol; 1995 Aug; 173(2):414-22; discussion 422-3. PubMed ID: 7645616
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.
Prendergast EN; Holman LL; Liu AY; Lai TS; Campos MP; Fahey JN; Wang X; Abdelaal N; Rao JY; Elvin JA; Moore KM; Konecny GE; Cohen JG
Gynecol Oncol; 2019 Sep; 154(3):461-466. PubMed ID: 31257009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
